Stonebridge Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100
| Closed | -$1.02K | – | 792 |
|
|
2023
Q3 | $1.02K | Hold |
100
| – | – | ﹤0.01% | 858 |
|
|
2023
Q2 | $753 | Hold |
100
| – | – | ﹤0.01% | 872 |
|
|
2023
Q1 | $885 | Hold |
100
| – | – | ﹤0.01% | 867 |
|
|
2022
Q4 | $912 | Hold |
100
| – | – | ﹤0.01% | 870 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 960 |
|
|
2022
Q2 | $1K | Sell |
100
-95
| -49% | -$950 | ﹤0.01% | 896 |
|
|
2022
Q1 | $2K | Hold |
195
| – | – | ﹤0.01% | 928 |
|
|
2021
Q4 | $2K | Hold |
195
| – | – | ﹤0.01% | 880 |
|
|
2021
Q3 | $2K | Sell |
195
-1,595
| -89% | -$16.4K | ﹤0.01% | 847 |
|
|
2021
Q2 | $19K | Buy |
1,790
+895
| +100% | +$9.5K | ﹤0.01% | 641 |
|
|
2021
Q1 | $10K | Buy |
+895
| New | +$10K | ﹤0.01% | 641 |
|
|
2020
Q3 | – | Sell |
-695
| Closed | -$9K | – | 652 |
|
|
2020
Q2 | $9K | Hold |
695
| – | – | ﹤0.01% | 508 |
|
|
2020
Q1 | $6K | Hold |
695
| – | – | ﹤0.01% | 544 |
|
|
2019
Q4 | $7K | Buy |
695
+200
| +40% | +$2.01K | ﹤0.01% | 607 |
|
|
2019
Q3 | $3K | Hold |
495
| – | – | ﹤0.01% | 681 |
|
|
2019
Q2 | $5K | Buy |
+495
| New | +$5K | ﹤0.01% | 682 |
|